“Once-Daily Intravenous Busulfan As Myeloablative, Reduced-Toxicity Conditioning Regimen: Results in Young and Adult Patients With Hematological Malignant and Nonmalignant Diseases”. 2009. Hematology Meeting Reports (formerly Haematologica Reports) 2 (6). https://doi.org/10.4081/hmr.v2i6.771.